BR112013031010A2 - composição compreendendo pelo menos um alginato para uso no tratamento e/ou prevenção de sobrepeso - Google Patents

composição compreendendo pelo menos um alginato para uso no tratamento e/ou prevenção de sobrepeso

Info

Publication number
BR112013031010A2
BR112013031010A2 BR112013031010A BR112013031010A BR112013031010A2 BR 112013031010 A2 BR112013031010 A2 BR 112013031010A2 BR 112013031010 A BR112013031010 A BR 112013031010A BR 112013031010 A BR112013031010 A BR 112013031010A BR 112013031010 A2 BR112013031010 A2 BR 112013031010A2
Authority
BR
Brazil
Prior art keywords
composition
alginate
overweight
prevention
treatment
Prior art date
Application number
BR112013031010A
Other languages
English (en)
Inventor
Brian Malm
Finn Larsen
Jens Steen Olsen
Original Assignee
Biotek Af 15 Marts 2006 1 Aps S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotek Af 15 Marts 2006 1 Aps S filed Critical Biotek Af 15 Marts 2006 1 Aps S
Publication of BR112013031010A2 publication Critical patent/BR112013031010A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734—Alginic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/256—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from seaweeds, e.g. alginates, agar or carrageenan
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pediatric Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Physiology (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

abstract a composition comprising at least one alginate for use in the treatment and/or prevention of overweight the present invention relates to a composition in the form of a powder or a viscous paste, said composition comprises at least one low viscosity alginate having a viscosity of less than about 100 mpas in a 1 wt% aqueous solution, and at least one high viscosity alginate having a viscosity of more than about 100 mpas in a 1 wt% aqueous solution, and wherein the composition further comprises at least one suspending agent, and thereby providing a composition, which is readily soluble in water such that an aqueous preparation can be prepared without substantive mixing. said aqueous preparation is suitable for use in the treatment and/or prevention of overweight for both therapeutic and non-therapeutic purposes. tradução resumo patente de invenção: "composição compreendendo pelo menos um alginato para uso no tratamento e/ou prevenção de sobrepeso". a presente invenção refere-se a uma composição na forma de um pó ou uma pasta viscosa, dita composição compreende pelo menos um alginato de baixa viscosidade tendo uma viscosidade de menos do que cerca de 100 mpas em uma solução aquosa a 1% em peso, e pelo menos um alginato de alta viscosidade tendo uma viscosidade de mais do que cerca de 100 mpas em uma solução aquosa a 1% em peso, e em que a composição ainda compreende pelo menos um agente de suspensão, e fornecendo assim uma composição que é facilmente solúvel em água de tal modo que uma preparação aquosa pode ser preparada sem mistura substantiva. dita prepa-ração aquosa é adequada para uso no tratamento e/ou prevenção do sobre-peso para os propósitos tanto terapêuticos quanto não terapêuticos.
BR112013031010A 2011-06-03 2012-03-01 composição compreendendo pelo menos um alginato para uso no tratamento e/ou prevenção de sobrepeso BR112013031010A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161493054P 2011-06-03 2011-06-03
DKPA201170283A DK177435B1 (en) 2011-06-03 2011-06-03 An aqueous diet product, a unit dosage and a kit comprising at least one alginate, and a method for the preparation of said diet product
PCT/DK2012/050192 WO2012163366A1 (en) 2011-06-03 2012-06-01 A composition comprising at least one alginate for use in treatment and/or prevention of overweight

Publications (1)

Publication Number Publication Date
BR112013031010A2 true BR112013031010A2 (pt) 2016-11-29

Family

ID=47258387

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013031010A BR112013031010A2 (pt) 2011-06-03 2012-03-01 composição compreendendo pelo menos um alginato para uso no tratamento e/ou prevenção de sobrepeso

Country Status (11)

Country Link
US (2) US9023828B2 (pt)
EP (1) EP2713773A1 (pt)
KR (1) KR20140043776A (pt)
CN (1) CN103717087A (pt)
AU (1) AU2012265310B2 (pt)
BR (1) BR112013031010A2 (pt)
CA (1) CA2837747A1 (pt)
DK (1) DK177435B1 (pt)
EA (1) EA029379B1 (pt)
MX (1) MX346467B (pt)
WO (1) WO2012163366A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014032676A1 (en) 2012-09-03 2014-03-06 S-Biotek Holding Aps A solid oral formulation for treatment and/or prevention of overweight and/or for stabilizing blood sugar levels in an individual.
GB2554039B (en) * 2016-05-06 2022-08-31 Freddy Hirsch Group Ag Coated Food Products

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID23809A (id) * 1997-04-30 2000-05-11 Reckitt & Colmann Prod Ltd Komposisi-komposisi alginat yang dapat dituang
GB9708773D0 (en) * 1997-04-30 1997-06-25 Reckitt & Colmann Prod Ltd Organic compositions
US6322724B1 (en) * 2000-01-05 2001-11-27 Isp Investments Inc. Products for controlling evaporative moisture loss and methods of manufacturing the same
US6989166B2 (en) 2001-12-20 2006-01-24 N.V. Nutricia Soft drink replacer
KR20060011960A (ko) * 2003-04-25 2006-02-06 고키붓산 유겐가이샤 변비 예방 및 개선제
BRPI0412633A (pt) 2003-09-03 2006-09-26 Unilever Nv composição comestìvel, uso de um agente espessante biopolimérico e método para induzir saciedade
CA2534523A1 (en) 2003-09-03 2005-03-10 Unilever Plc Satiety enhancing food compositions
US20070082025A1 (en) * 2005-10-07 2007-04-12 Catani Steven J Methods for achieving and maintaining weight loss
US20070082084A1 (en) 2005-10-07 2007-04-12 Catani Steven J Methods for weight management
US20070082029A1 (en) 2005-10-07 2007-04-12 Aimutis William R Fiber satiety compositions
US20070082030A1 (en) 2005-10-07 2007-04-12 Aimutis William R Fiber satiety compositions
US20070082114A1 (en) * 2005-10-07 2007-04-12 Catani Steven J Methods for reducing weight
CA2624554A1 (en) * 2005-10-07 2007-04-19 Cargill, Incorporated Fiber satiety compositions
EP2120603B1 (en) 2007-02-13 2021-05-12 S-Biotek af 15. marts 2006 1 ApS Diet product comprising alginate
HUE038093T2 (hu) * 2009-03-13 2018-09-28 Excellent Tech Products I Sverige Ab Orális bejuttatású termék

Also Published As

Publication number Publication date
US9023828B2 (en) 2015-05-05
EA201391776A1 (ru) 2014-08-29
WO2012163366A1 (en) 2012-12-06
CN103717087A (zh) 2014-04-09
EP2713773A1 (en) 2014-04-09
MX346467B (es) 2017-03-22
CA2837747A1 (en) 2012-12-06
AU2012265310A1 (en) 2014-01-16
AU2012265310B2 (en) 2015-07-16
US20140128342A1 (en) 2014-05-08
DK177435B1 (en) 2013-05-21
EA029379B1 (ru) 2018-03-30
DK201170283A (en) 2012-12-04
US20160015736A1 (en) 2016-01-21
KR20140043776A (ko) 2014-04-10
MX2013014125A (es) 2014-04-30
US9597350B2 (en) 2017-03-21

Similar Documents

Publication Publication Date Title
BR112013029920A2 (pt) composição de cobertura misturável, cobertura de mistura, uso da composição de cobertura misturável e método para preparar a composição de cobertura misturável
BR112014026307A2 (pt) preparação injetável
MX2020012041A (es) Formulacion farmaceutica.
BR112017009984A2 (pt) composições de gel de óxido de metal quelado
MX2018006919A (es) Composiciones de emulsion inversas.
WO2011134937A3 (en) Pharmaceutical emulsion compositions comprising progestogen
MX360833B (es) Formulacion acuosa esteril inyectable basada en acido hialuronico reticulado e hidroxiapatita para uso para estético.
BR112014010275A2 (pt) formulações para tratamento de diabetes
MY161022A (en) Dexmedetomidine premix formulation
BR112014004687A2 (pt) imidazopiridazinas amino-substituídas
BR112015012531A2 (pt) composições alimentícias de pseudo pão
BR112018003877A2 (pt) “composição farmacêutica, método para reduzir a gordura subcutânea, método para a redução de peso corporal e uso de uma composição farmacêutica”
BR112014007471A2 (pt) agente de tropicalização
AR060784A1 (es) Mezclas binarias de acido hialuronico y su uso terapeutico
BR112015032370A2 (pt) derivados de biarila, composição, e, método para preparar uma composição
BR112015011896A2 (pt) derivado fotorreativo de ácido hialurônico, método de preparação do derivado fotorreativo, método de preparação de derivados 3d reticulados de ácido hialurônico, derivado 3d reticulado de ácido hialurônico e uso do derivado 3d reticulado
BR112014019730A8 (pt) Sistema tensoativo estruturado aquoso e composição de cuidado pessoal
SI2680834T1 (en) A semi-aqueous aqueous pharmaceutical composition containing tapentadol
SG10201805571PA (en) Hyaluronic acid compositions including mepivacaine
MX356892B (es) Composiciones nutricionales liquidas, claras estables en anaquel que comprenden galato de epigalocatequina (egcg) y metodos para prepararlas.
BR112015029911A2 (pt) bolo alimentar líquido coesivo compreendendo moléculas que fornecem viscoelasticidade
BR112012015016A8 (pt) Formulação farmacêutica, forma de dosagem farmacêutica entérica e uso de uma formulação
BR112013031010A2 (pt) composição compreendendo pelo menos um alginato para uso no tratamento e/ou prevenção de sobrepeso
BR112015017040A2 (pt) aumento de volume muscular em um ser humano com o uso de ácido hialurônico
BR112015032853A2 (pt) produto de tratamento oral e método de remineralização de dente

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law
B15K Others concerning applications: alteration of classification

Ipc: A61K 31/734 (2006.01), A23L 29/256 (2016.01), A23L

B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa)

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 7A ANUIDADE.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2517 DE 02-04-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.